Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Harpoon Therapeutics, Inc. (HARP)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsJun-30-23Mar-31-23Dec-31-22Sep-30-22Sep-05-22Jun-30-22Jun-05-22Mar-31-22
   10-Q10-Q10-K10-Q8-K10-Q8-K10-Q
Revenues  46.534.631.932.232.223.0 20.6
            Revenue growth  102.1%68.3%34.9%19.9% -12.2% -11.2%
Cost of goods sold  0.00.025.50.077.40.0 0.0
Gross profit  46.534.631.932.2-45.323.0 20.6
            Gross margin  100.0%100.0%100.0%100.0%-140.9%100.0% 100.0%
Selling, general and administrative   [+]71.572.779.682.720.278.3 95.9
Research and development  12.2    20.7  
Other operating expenses      5.7   
EBITDA   [+]-34.9-56.3-65.9-68.9 -73.7 -73.0
            EBITDA margin  -75.0%-162.7%-206.6%-214.3%-221.3%-320.1% -355.4%
Depreciation and amortization  2.32.52.42.2 2.3 2.3
EBIT   [+]-37.1-58.8-68.3-71.2-71.2-75.9 -75.3
            EBIT margin  -79.9%-169.9%-214.1%-221.3%-221.3%-329.9% -366.4%
Non-recurring items   [+]1.7       
Interest income, net   [+]-0.90.10.10.10.50.1 0.2
Other income (expense), net   [+]-0.50.10.50.2-0.2-0.1 -0.2
Pre-tax income  -40.3-58.7-67.7-70.9-70.9-75.9 -75.3
Income taxes  0.00.00.00.00.00.0 0.0
            Tax rate  0.0%0.0%0.0%0.0%0.0%0.0% 0.0%
Net income  -40.3-58.7-67.7-70.9-70.9-75.9 -75.3
            Net margin  -86.7%-169.8%-212.2%-220.4%-220.4%-329.8% -366.5%
   
Basic EPS   [+]($1.15)($1.72)($2.05)($2.16)($2.15)($2.32) ($2.31)
Diluted EPS   [+]($1.14)($1.72)($2.05)($2.16)($2.15)($2.32) ($2.31)
   
Shares outstanding (basic)   [+]35.234.133.032.832.932.7 32.6
Shares outstanding (diluted)   [+]35.334.133.032.832.932.7 32.6
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy